Evaluation of Acid-Fast Bacilli (AFB) Smear Microscopy as a Follow-Up Tool IN Tuberculosis Patients at Mile 4 Hospital, Abakaliki

Authors

Sunday Onwe Ogamde

Department of Medical Laboratory Science, Alex-Ekwueme Federal University Ndufu Alike, Ebonyi State, Nigeria (Nigeria)

Ugwu Jude Iheanacho

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Chinemerem Chukwuka Ogbu

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Chiedozie Kenechi Chikwendu

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Ukpo Kingsley onwe

Department of Medical Laboratory Science, Alex-Ekwueme Federal University Ndufu Alike, Ebonyi State, Nigeria (Nigeria)

Esther Ifeyinwa Etu

Department of Anatomic Pathology, Alex-Ekwueme Federal University Ndufu Alike, Ebonyi State, Nigeria (Nigeria)

Maduka-Ome Victory Chidera

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Uhuo Angela Njideka

Ebonyi State University, Abakaliki, Ebonyi State, Nigeria (Nigeria)

Nnamdi Ngozika Amarachi

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Chukwuagoziem Edwin Ebubechukwu

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Odile Oshonameh Prince

Department of Medical Laboratory Science, College of Health Sciences, Evangel University, Akaeze, Ebonyi State, Nigeria (Nigeria)

Article Information

DOI: 10.51244/IJRSI.2026.1310000190

Subject Category: Medical Laboratory Science

Volume/Issue: 13/10 | Page No: 4873-4882

Publication Timeline

Submitted: 2026-10-18

Accepted: 2026-10-23

Published: 2026-11-13

Abstract

Tuberculosis (TB) remains a major public health problem, and effective follow-up during treatment is essential for monitoring patient response and reducing disease transmission. This study evaluated the diagnostic performance and follow-up effectiveness of Acid-Fast Bacilli (AFB) smear microscopy among TB patients attending Mile 4 Hospital, Abakaliki, Ebonyi State. A descriptive prospective observational study design was adopted, enrolling a consecutive sample of 75 confirmed pulmonary TB patients presenting for follow-up evaluation. For each participant, paired sputum specimens were collected at a single follow-up visit and evaluated simultaneously by Ziehl–Neelsen (ZN) AFB smear microscopy and mycobacterial culture on Lowenstein–Jensen (L-J) medium, which served as the reference gold standard. Data were analyzed using SPSS (version 26.0), with categorical variables presented as frequencies and percentages. Diagnostic accuracy estimates were reported with exact 95% confidence intervals (95% CI). Overall, 53.3% (40/75) of participants were culture-positive on L-J medium, while 68.0% (51/75) were smear-positive.
A statistically significant association was observed between AFB smear microscopy grades and culture outcomes (χ² = 34.41, df = 3, p < 0.001). Among a subgroup of 24 patients evaluated after receiving at least three months of anti-TB therapy, smear conversion (defined as two consecutive negative AFB smears collected 24 hours apart in a patient initially smear-positive at baseline) was achieved in 66.7% (16/24), whereas 33.3% (8/24) remained smear-positive. AFB smear microscopy demonstrated a sensitivity of 95.0% (95% CI: 83.5%–98.6%), specificity of 62.9% (95% CI: 46.3%–76.8%), positive predictive value of 74.5% (95% CI: 61.1%–84.5%), and negative predictive value of 91.7% (95% CI: 94.2%–97.7%). The study concluded that AFB smear microscopy is a useful, reliable, and affordable frontline method for monitoring tuberculosis treatment in resource-limited settings because of its high sensitivity. However, solid Lowenstein–Jensen culture remains essential for confirming treatment outcomes, particularly in patients who remain smear-positive during follow-up.

Keywords

Acid-Fast Bacilli, Smear Microscopy, Tuberculosis, Prospective Follow-Up, Lowenstein–Jensen Medium, Smear Conversion, Diagnostic Accuracy.

Downloads

References

1. World Health Organization. (2023). Global Tuberculosis Report 2023. World Health Organization, Geneva. [Google Scholar] [Crossref]

2. Nwokoye, I. C., & Ugwu, L. N. (2022). Assessment of tuberculosis treatment outcomes and associated factors in Ebonyi State, Nigeria. West African Journal of Public Health, 12(3), 88–97. [Google Scholar] [Crossref]

3. Adewole, O. O., Adebayo, A. M., & Ojo, O. E. (2022). Evaluation of smear microscopy in monitoring tuberculosis treatment outcomes in Nigeria. African Journal of Medical Sciences, 45(2), 123–131. [Google Scholar] [Crossref]

4. Federal Ministry of Health. (2023). National Tuberculosis, Leprosy and Buruli Ulcer Control Programme: Guidelines for Tuberculosis Control in Nigeria. FMoH, Abuja. [Google Scholar] [Crossref]

5. Cheesbrough, M. (2019). District Laboratory Practice in Tropical Countries (2nd ed.). Cambridge University Press, Cambridge. [Google Scholar] [Crossref]

6. Eze, C. N., Nworie, A. E., & Ohaeri, M. C. (2023). Follow up smear microscopy and treatment outcomes among TB patients in Southeast Nigeria. Nigerian Journal of Clinical Laboratory Science, 8(1), 45–53. [Google Scholar] [Crossref]

7. Ştefanescu, S., Popa, M., & Arghir, O. (2021). The role of smear microscopy in monitoring tuberculosis treatment outcomes. Romanian Journal of Infectious Diseases, 24(2), 95–102. [Google Scholar] [Crossref]

8. Balepur, S. K., & Schlossberg, D. (1999). Tuberculosis and Nontuberculous Mycobacterial Infections (4th ed.). W.B. Saunders, Philadelphia. [Google Scholar] [Crossref]

9. Agyeman, A. A., & Ofori-Asenso, R. (2017). Tuberculosis—an overview. Journal of Public Health and Emergency, 1(1), 7. [Google Scholar] [Crossref]

10. Mohammad, K. K. (2019). An overview on epidemiology of tuberculosis. Mymensingh Medical Journal, 28(4), 940–948. [Google Scholar] [Crossref]

11. Kone, B., Somboro, A. M., Holl, J. L., Baya, B., Togo, A. A., Sarro, S., Diarra, B., Kodio, O., Murphy, R. L., Bishai, W., Maiga, M., & Doumbia, S. (2020). Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: A systematic review. International Journal of Molecular Epidemiology and Genetics, 11(1), 1–12. [Google Scholar] [Crossref]

12. Sulis, G., Roggi, A., Matteelli, A., & Raviglione, M. C. (2014). Tuberculosis: Epidemiology and control. Mediterranean Journal of Hematology and Infectious Diseases, 6(1), e2014045. [Google Scholar] [Crossref]

13. Olaleye, S. A., Balogun, O. S., & Adusei-Mensah, F. (2023). Bibliometric structured review of tuberculosis in Nigeria. African Health Sciences, 23(2), 139–160. [Google Scholar] [Crossref]

14. Alsayed, S. S. R., & Gunosewoyo, H. (2023). Tuberculosis: Pathogenesis, current treatment regimens and new drug targets. International Journal of Molecular Sciences, 24(6), 5202. [Google Scholar] [Crossref]

15. Bayot, M. L., Sharma, S., & Mirza, T. M. (2023). Acid Fast Bacteria. StatPearls Publishing, Treasure Island, FL. [Google Scholar] [Crossref]

16. World Health Organization. (2024). Tuberculosis: Multidrug-Resistant Tuberculosis (MDR-TB). World Health Organization, Geneva. [Google Scholar] [Crossref]

17. World Health Organization. (2018). Tuberculosis: Extensively Drug-Resistant Tuberculosis (XDR-TB). World Health Organization, Geneva. [Google Scholar] [Crossref]

18. ResearchGate. (2022). Pathogenesis of M. tuberculosis infection [Scientific Diagram]. ResearchGate GmbH. Available from: https://www.researchgate.net [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles